Page 38 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

K taka to shift Covid patients to dedicated centre in villages

K taka to shift Covid patients to dedicated centre in villages
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.

Health departmentSerum institute of indiaCovid care centresHealth ministerPune based serum instituteHyderabad based bharat biotechஆரோக்கியம் துறைசீரம் நிறுவனம் ஆஃப் இந்தியாஆரோக்கியம் அமைச்சர்புனே அடிப்படையிலானது சீரம் நிறுவனம்ஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்

More pharma firms should be allowed to make Covid vaccine: Nitin Gadkari

More pharma firms should be allowed to make Covid vaccine: Nitin Gadkari
indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshNitin gadkariNarendra modiArvind kejriwalSerum institute of indiaImage sourceMinister nitin gadkariPune based serum institutePrime minister narendra modiBharat biotechஆந்திரா பிரதேஷ்நிடின் கட்காரிநரேந்திர மோடிஅரவிந்த் கேஜ்றிவாள்சீரம் நிறுவனம் ஆஃப் இந்தியாபடம் மூல

Health ministry releases list of blood clot symptoms after taking Covishield

According to the AEFI Committee, it has completed an in-depth case review of 498 serious and severe events, of which 26 cases have been reported to be potential thromboembolic (formation of a clot in a blood vessel that might also break loose and carried by the bloodstream to plug another vessel) events - following the administration of Covishield vaccine - with a reporting rate of 0.61 cases per million doses. The Union health ministry said on Monday that the number of blood clot cases in people who received AstraZeneca s Covid-19 vaccine (called Covishield) in India was minuscule . Covishield - one of three shots granted emergency approval in India - is the most widely used in the country and is manufactured by Pune-based Serum Institute (SII).

Astrazeneca covidSerum institutePune based serum instituteAdverse event following immunisationசீரம் நிறுவனம்புனே அடிப்படையிலானது சீரம் நிறுவனம்

It would take 2-3 years for entire world population to get fully vaccinated, says SII CEO Adar Poonawalla

It would take 2-3 years for entire world population to get fully vaccinated, says SII CEO Adar Poonawalla
india.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from india.com Daily Mail and Mail on Sunday newspapers.

New delhiAdar poonawallaSerum institute of indiaPune based serum instituteEmergency use authorizationபுதியது டெல்ஹிஅடார் பூனாவல்லசீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்அவசரம் பயன்பாடு அங்கீகாரம்

Delhi HC adjourns hearing on PIL seeking reduction in price of Covid-19 vaccine

Delhi HC adjourns hearing on PIL seeking reduction in price of Covid-19 vaccine ANI | Updated: May 17, 2021 14:23 IST New Delhi [India], May 17 (ANI): The Delhi High Court on Monday adjourned the hearing on a Public Interest Litigation (PIL) that sought direction to the respondents to reduce the price of anti-coronavirus vaccine for citizens of the country. The bench of Justice DN Patel and Justice Jyoti Singh deferred the matter after taking note that the Supreme Court of India is already examining a similar matter. The petitioner Rakesh, social activist, through Advocates AK Dubey and Pawan Kumar stated that earlier the price of vaccine at a private hospital was Rs 250, which was reasonable. It is not easy for most people to pay the increased cost of anti-Corona vaccine as it raises the expenses of the common people.

New delhiWest bengalTamil naduPawan kumarJustice jyoti singhSupreme courtUnion of indiaDelhi high court onSerum institute of indiaMinistry of external affairsDelhi high courtPublic interest litigationHyderabad based bharat biotechPune based serum instituteSri lankaExternal affairs